Viewing Study NCT04714827


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-02-05 @ 11:32 PM
Study NCT ID: NCT04714827
Status: RECRUITING
Last Update Posted: 2023-12-29
First Post: 2021-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: Shanxi Province Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords: